Skip to main content
. 2018 Mar 2;97(9):e9874. doi: 10.1097/MD.0000000000009874

Figure 3.

Figure 3

The pathological examinations. (A) The lesion (hematoxylin–eosin staining, 100×). (B) The necrosis area of the lesion (hematoxylin–eosin staining, 100×). (C) Non necrotic area of the lesion (hematoxylin–eosin staining, 200×). (D) Positive CD34 staining (immunohistochemisty staining, 100×). (E) Positive CD117 staining (immunohistochemisty staining, 200×). (F) Positive Dog-1 staining (immunohistochemisty staining, 200×).